TP53 mutation is an early event in breast cancer progression

被引：0
|
作者：
Zhou, W.
Muggerud, A. A.
Vu, P.
Due, E. U.
Sorlie, T.
Borresen-Dale, A-L
Warnberg, F.
Langerod, A.
机构：
[1] Univ Uppsala Hosp, Uppsala, Sweden
[2] Norwegian Radium Hosp, Inst Canc Res, Oslo, Norway
来源：
CANCER RESEARCH | 2009年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：120S / 120S
页数：1
相关论文
共 50 条
  • [41] Discovering the co-drivers of mutant TP53 that promote breast cancer progression
    Pal, Anasuya
    Park, Jin
    LaBaer, Joshua
    CANCER RESEARCH, 2018, 78 (13)
  • [42] Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer
    Hassan, Nur Mohammad Monsur
    Tada, Mitsuhiro
    Hamada, Jun-ichi
    Kashiwazaki, Haruhiko
    Kameyama, Takeshi
    Akhter, Rahena
    Yamazaki, Yutaka
    Yano, Masahiro
    Inoue, Nobuo
    Moriuchi, Tetsuya
    CANCER LETTERS, 2008, 270 (01) : 108 - 119
  • [43] TP53 haplotypes and susceptibility to breast cancer.
    Kristensen, Vessela
    Garcia-Closas, Montserrat
    Langerod, Anita
    Qi, Ying
    Yeager, Meredith
    Burdett, Laurie
    Welch, Robert
    Lissowska, Jolanta
    Peplonska, Beata
    Bardin-Mikolajczak, Alicija
    Brinton, Louise
    Gerhard, Daniela S.
    Perou, Charles
    Borresen-Dale, Anne-Lise
    Chanock, Stephen
    CANCER RESEARCH, 2006, 66 (08)
  • [44] Germline mutations of TP53 gene in breast cancer
    Damineni, Surekha
    Rao, Vadlamudi Raghavendra
    Kumar, Satish
    Ravuri, Rajasekar Reddy
    Kagitha, Sailaja
    Dunna, Nageswara Rao
    Digumarthi, Raghunadharao
    Satti, Vishnupriya
    TUMOR BIOLOGY, 2014, 35 (09) : 9219 - 9227
  • [45] THE ROLE OF TP53 IN BREAST-CANCER DEVELOPMENT
    EELES, RA
    BARTKOVA, J
    LANE, DP
    BARTEK, J
    CANCER SURVEYS, 1993, 18 : 57 - 75
  • [46] TP53 status and response to chemotherapy in breast cancer
    Bertheau, Philippe
    Espie, Marc
    Turpin, Elisabeth
    Lehmann, Jacqueline
    Plassa, Louis-Francois
    Varna, Mariana
    Janin, Anne
    de The, Hugues
    PATHOBIOLOGY, 2008, 75 (02) : 132 - 139
  • [47] TP53 as a predictor of response to chemotherapy in breast cancer
    Lonning, PE
    Johnsen, H
    Geisler, S
    Aas, T
    Smith-Sorensen, B
    Akslen, LA
    Borresen-Dale, AL
    PRIMARY MEDICAL THERAPY FOR BREAST CANCER: CLINICAL AND BIOLOGIC AL ASPECTS, 1999, 4 : 73 - 88
  • [48] Sarcomas in TP53 Germline Mutation Carriers A Review of the IARC TP53 Database
    Ognjanovic, Simona
    Olivier, Magali
    Bergemann, Tracy L.
    Hainaut, Pierre
    CANCER, 2012, 118 (05) : 1387 - 1396
  • [49] TP53 Mutation in Waldenstrom Macroglobulinemia
    Poulain, Stephanie
    Roumier, Christophe
    Bertrand, Elisabeth
    Renneville, Aline
    Tricot, Sabine
    Venet, Aurelie Caillault
    Geffroy, Sandrine
    Nudel, Morgan
    Herbaux, Charles
    Guidez, Stephanie
    Preudhomme, Claude
    Leleu, Xavier
    BLOOD, 2016, 128 (22)
  • [50] TP53 mutation in ovarian carcinoma
    Murphy, M
    McManus, DT
    Toner, PG
    Russell, SEH
    EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1281 - 1283
12345